Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
146.82
-1.71 (-1.15%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
92
93
Next >
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 12, 2024
These incredible businesses have long histories of successes behind them, and more to come.
Via
The Motley Fool
Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now
February 12, 2024
If you are looking to build wealth through dividend income, here are the passive income blue-chip stocks to buy.
Via
InvestorPlace
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
February 09, 2024
Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024.
Via
Benzinga
Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income
February 09, 2024
Unlock reliable cash flow with these Dividend Aristocrats. They're elite S&P 500 dividend stocks raising payouts for 25+ years.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Looking Into Johnson & Johnson's Recent Short Interest
February 07, 2024
Via
Benzinga
Is Johnson & Johnson Stock a Buy Now?
February 07, 2024
Don't overlook this boring company's stellar reliability.
Via
The Motley Fool
3 High Yield Dividend Aristocrats To Buy Now
February 02, 2024
The Dividend Aristocrats have increased their dividends every year for at least 25 years in a row.
Via
Talk Markets
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
Via
Benzinga
3 Dividend Stocks to Cling to This Year
February 09, 2024
Build a retirement portfolio with these three dividend stocks to enjoy passive income and capital growth over the years.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
The Watch List: Is Warren Buffett Still Selling These 3 Stocks?
February 08, 2024
Just because Warren Buffett marked these as stocks to sell doesn't always mean investors need to walk lockstep with him.
Via
InvestorPlace
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
February 08, 2024
The healthcare conglomerate has been raising its dividend payout since Kennedy was president, but there have been some recent changes.
Via
The Motley Fool
7 Dividend Stocks Worth Holding for the Long Haul
February 06, 2024
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly.
Via
InvestorPlace
Analyzing NYSE:JNJ's Dividend Potential.
January 30, 2024
Is JOHNSON & JOHNSON (NYSE:JNJ) a Good Fit for Dividend Investing?
Via
Chartmill
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
February 06, 2024
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements.
Via
InvestorPlace
New Hope For Patients With Chronic Autoimmune Conditions: Johnson & Johnson's Investigational Drug Meets Primary Goal In Two Studies
February 05, 2024
Johnson & Johnson's nipocalimab shows promise in Phase 3 VIVACITY for gMG & Phase 2 DAHLIAS for SjD. FDA-approved Vyvgart Hytrulo for gMG.
Via
Benzinga
2 Healthcare Dividend Kings to Buy and Hold Forever
February 04, 2024
It's going to take a lot to interrupt these companies' streaks.
Via
The Motley Fool
7 Dividend Stocks That Pay Me More Than $500 Per Month
February 03, 2024
These stocks pay safe, reliable, and growing dividends.
Via
The Motley Fool
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
The Inflation Reduction Act's impact on drug prices. Medicare challenges pharmaceutical costs, offering relief to seniors and addressing the soaring prices in the U.S. healthcare system.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
FDA Hosts Public Psychedelics Discussion, Discloses Major Growth On Number Of New Psychiatric Drugs Filings Post-2000
January 31, 2024
FDA and Reagan-Udall Foundation are hosting a virtual public meeting on psychedelic research titled Advancing Psychedelic Clinical Study Design, which aims to explore empirical approaches to address...
Via
Benzinga
Exposures
Product Safety
The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024
January 31, 2024
Investors looking for reliable stocks that can be expected to continuously rise and provide strong returns should consider these names.
Via
InvestorPlace
Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot
January 30, 2024
Healthcare stocks to buy are not talked about as much right now, but are great stocks investors should consider adding.
Via
InvestorPlace
Medicare's Historic Negotiations To Lower Drug Prices, Analysts Anticipate Upto Potential Price Cuts Of 60%
January 30, 2024
Explore the impact of the U.S. government's proposal on pharmaceuticals! Learn about Medicare's negotiation power, potential price cuts, and industry reactions.
Via
Benzinga
Will Novo Nordisk Be a $1 Trillion Company by 2030?
January 30, 2024
Novo Nordisk's market cap has ballooned thanks to the overwhelming success of its Ozempic, Wegovy, and Rybelsus medications.
Via
The Motley Fool
Wall Street's Greatest Dividend Stock Just Made History Again, and 99% of Investors Probably Don't Realize It Exists
January 30, 2024
This virtually unknown company has been paying a consecutive dividend to its investors for more than 200 years.
Via
The Motley Fool
3 Perfect Stocks for Retirees to Buy Hand Over Fist in the New Bull Market
January 30, 2024
These industry-leading, time-tested companies are ideal for retired investors.
Via
The Motley Fool
Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
January 29, 2024
Team up with the schoolyard bully so to speak with these compelling ideas for hedge fund favorite stocks to buy.
Via
InvestorPlace
Johnson & Johnson To Pay $149M In Opioid Settlement, Washington State AG Says 'We Are Not Done'
January 29, 2024
J&J settles opioid lawsuit with Washington state for $149.5 million in one lump sum, giving more resources to fight the fentanyl crisis.
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
January 27, 2024
These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?
Via
The Motley Fool
Should You Buy the Dogs of the Dow in 2024?
January 27, 2024
The popular dividend-investing strategy has been around for years. Is it right for you?
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
92
93
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.